Yokohama, Japan

Yasushi Murakami

This inventor holds 14 USPTO granted patents and 2 EPO patents. Top assignees: Kabushiki Kaisha Toshiba, Pola Pharma Inc.. Active years: 2000-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasushi Murakami. Retrieved from https://idiyas.com/inventor/yasushi-murakami-ex5fb7as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 904(Granted Patents)


Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Yasushi Murakami: Innovator in Pharmaceutical Composition

Introduction

Yasushi Murakami is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work focuses on enhancing the stability and effectiveness of pharmaceutical compositions.

Latest Patents

Among his latest patents, Yasushi has developed a pharmaceutical composition aimed at improving the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole. This composition is designed to maintain the compound's efficacy while incorporating a chelating agent. The innovative approach ensures that the pharmaceutical product remains effective over time.

Career Highlights

Yasushi has had a distinguished career, working with notable companies such as Toshiba Corporation and Pola Pharma Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Throughout his career, Yasushi has collaborated with talented individuals, including Naoko Kobayashi and Azuma Nishio. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yasushi Murakami stands out as a key figure in the pharmaceutical industry, with a focus on enhancing drug stability and effectiveness. His innovative work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…